MEDIA CENTRE    |    PRINT    |     FRANÇAIS
   

Welcome to the Lady Davis Institute
 
The Lady Davis Institute (LDI) is the research arm of Montreal's Jewish General Hospital, a teaching hospital of McGill University.
 
Founded in 1969, the LDI is one of Canada's leading health research institutes. Important discoveries which have contributed to the health and well-being of patients in Quebec, Canada, and around the world, have been made by LDI researchers in the areas of HIV/AIDS, aging, cancer, vascular disease, epidemiology, and psychosocial science. There are currently more than 117 full-time researchers at the LDI, of whom 70 are primarily lab-based, 21 investigate psychosocial aspects of disease, 26 are in epidemiology. In addition, there are 124 associate investigators. 
 
 

 
Pharma and Biotech:
Collaborate with the LDI
 
 
 
 
                         
 
News from the LDI
 
20/03/2017
Long-term limitations imposed on patients with pulmonary embolism
New clinical study, led by the Jewish General Hospital, determines that close to half of patients who suffer a blood clot in their lung will experience exercise limitations at one year.

 more...

26/01/2017
Study concludes that androgen deprivation therapy is not associated with increased risk of Alzheimer disease in patients with prostate cancer
Researchers at the Lady Davis Institute have concluded that methodological issues were responsible for an earlier study’s controversial finding that a common treatment for late stage prostate cancer was associated with Alzheimer disease and other forms of dementia. Their more robust work has concluded that no such association exists.

 more...



Copyright © 2010 Lady Davis Institute/Jewish General Hospital.
Created by Blue Lemon Media Inc.
Sitemap | Disclaimer